Dinutuximab-Associated Neurotoxicity: Incidence, Presentation, Risk Factors, and Nursing Interventions
{{output}}
BackgroundDinutuximab, a GD2-directed monoclonal antibody, is now incorporated into therapy for high-risk and relapsed or refractory neuroblastoma. Despite its boxed warning for drug-induced neurotoxicity, little is known about the incidence, risk factors, mon... ...
